Subscribe to our Newsletters !!

    drug

    Interest for ayurvedic healthcare items increments in the midst of COVID-19 emergency

    In the midst of the coronavirus flare-up, the interest for ayurvedic items with medical advantages and invulnerability building characteristics has expanded the country over, Business Standard has detailed. As indicated by the report, organizations like Dabur and Himalaya Wellness said they have seen an expansion sought after for ayurvedic items across portfolios. The interest for

    Lupin dispatches generic rheumatoid arthritis drug in US market

    Medicine manufacturer Lupin on Wednesday said it has established Leflunomide pills, used to treat rheumatoid arthritis, even in the US marketplace. The business has established the product in 10 mg and 20 mg strengths after receiving the approval by the US Food and Drug Administration (USFDA) before, Lupin said in a statement. The item could

    Innovations Assist Compound Management in Pharma Drug Discovery

    Ziath has released a module to enable their Mirage, Cube or Express tube readers to decode Brooks Acoustix tubes. Acoustix is a small sample tube with a screw cap which is increasingly favored for storage of novel compounds in solution in large compound stores. It is also compatible with the latest generation of Labcyte Echo

    Compact, High Resolution Chromatography Flowmeter

    TESTA Analytical Solutions e.K. has developed a new flowmeter which enables continuous measurement of flow rate without interference in chromatography systems. Flow rate is one of the most important parameters in any liquid chromatography system, it determines retention time or volume and has by nature a major influence on reproducibility. Compatible with all HPLC and

    Dr Reddy’s gets 3 perceptions from USFDA for US-based API plant

    Dr Reddy’s Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its Production facility in Middleburg, New York. The audit of the business’s active pharmaceutical ingredients (API) manufacturing plant at Middleburg, New York has been completed from the US Food and Drug Administration (USFDA), the Hyderabad-based

    Cipla launches initiative to improve access to nebulisers for acute asthma management in primary health care centres of rural India

    Mumbai, 10th December 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced a first-of-its-kind initiative to improve access to nebulization therapy specifically for patients in the rural sections of the country. With Cipla’s unmatched presence across the care continuum and a wide range of drug-device combinations and treatments, the